vmx-c001
Recombinant proteinexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 29, 2021 (NCT05152420)
Timeline
Indications
Studied for
Mechanism of action
- Coagulation factor XSupplementation
F10 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07288489 | Phase 3 | Jan 31, 2026 | VarmX B.V. |
| NCT06517563 | Phase 1 | Aug 14, 2024 | VarmX B.V. |
| NCT06372483 | Phase 1 | Feb 21, 2024 | VarmX B.V. |
| NCT05152420 | Phase 1 | Oct 29, 2021 | VarmX B.V. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| VarmX B.V. | For profit | 4 | 4 | 2 | 2021 |
1 organizations
Page 1 / 1